FOLD

NASDAQ · Biotechnology

Amicus Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$14.49

+0.03 (+0.21%)

As of May 8, 9:55 PM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 6 43%

Hold 8 57%

Sell 0 0%

Price Target

Analyst Price Target +619.5% upside

Low Target $68.91

Average Target $104.26

High Target $125.13

Current Price $14.49

Current
$14.49

Target
$104.26

$68.91 $104.26 avg $125.13

Scenario Analysis

Bear Case

$68.91

375.6%

Low target

Base Case

$104.26

+619.5%

Avg target

Bull Case

$125.13

+763.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$14.50

-0.1% from high

52-Week Low

$5.51

+163.0% from low

50-Day SMA

$13.59

+6.6% vs SMA

200-Day SMA

$8.96

+61.7% vs SMA

RSI (14)

72.2

Overbought

Target vs 52W High

$104.26

+619.0% vs high

Next Earnings Report

May 13, 2026

until earnings

EPS Est: $0.03

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%